N- and O-glycosylation Analysis of Human C1-inhibitor Reveals Extensive Mucin-type O-Glycosylation

Human C1-inhibitor (C1-Inh) is a serine protease inhibitor and the major regulator of the contact activation pathway as well as the classical and lectin complement pathways. It is known to be a highly glycosylated plasma glycoprotein. However, both the structural features and biological role of C1-I...

Full description

Saved in:
Bibliographic Details
Published inMolecular & cellular proteomics Vol. 17; no. 6; pp. 1225 - 1238
Main Authors Stavenhagen, Kathrin, Kayili, H. Mehmet, Holst, Stephanie, Koeleman, Carolien A.M., Engel, Ruchira, Wouters, Diana, Zeerleder, Sacha, Salih, Bekir, Wuhrer, Manfred
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.06.2018
American Society for Biochemistry and Molecular Biology
The American Society for Biochemistry and Molecular Biology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Human C1-inhibitor (C1-Inh) is a serine protease inhibitor and the major regulator of the contact activation pathway as well as the classical and lectin complement pathways. It is known to be a highly glycosylated plasma glycoprotein. However, both the structural features and biological role of C1-Inh glycosylation are largely unknown. Here, we performed for the first time an in-depth site-specific N- and O-glycosylation analysis of C1-Inh combining various mass spectrometric approaches, including C18-porous graphitized carbon (PGC)-LC-ESI-QTOF-MS/MS applying stepping-energy collision-induced dissociation (CID) and electron-transfer dissociation (ETD). Various proteases were applied, partly in combination with PNGase F and exoglycosidase treatment, in order to analyze the (glyco)peptides. The analysis revealed an extensively O-glycosylated N-terminal region. Five novel and five known O-glycosylation sites were identified, carrying mainly core1-type O-glycans. In addition, we detected a heavily O-glycosylated portion spanning from Thr82-Ser121 with up to 16 O-glycans attached. Likewise, all known six N-glycosylation sites were covered and confirmed by this site-specific glycosylation analysis. The glycoforms were in accordance with results on released N-glycans by MALDI-TOF/TOF-MS/MS. The comprehensive characterization of C1-Inh glycosylation described in this study will form the basis for further functional studies on the role of these glycan modifications.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Authors equally contributed to this work.
Author contributions: K.S., H.M.K., R.E., D.W., S.Z., B.S., and M.W. designed research; K.S., H.M.K., S.H., and C.K. performed research; K.S., H.M.K., S.H., and C.K. analyzed data; K.S., H.M.K., S.H., R.E., and M.W. wrote the paper.
ISSN:1535-9476
1535-9484
1535-9484
DOI:10.1074/mcp.RA117.000240